ADMA Biologics CEO Disposes of 21,000 Shares, Exercises Options for Additional 15,000
ADMA Biologics’ chief executive, Adam S. Grossman, sold 21,000 shares on March 16, 2026, while exercising options to acquire 15,000 additional shares the same day. The moves leave Grossman with substantial direct and indirect holdings as the company trades around $16.15 with a market capitalization of $3.85 billion. Recent fourth-quarter 2025 resul…